Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03588624 · ClinicalTrials.gov registry record · NA

Study of the TearCare System in Dry Eye Disease

A NA study of Dry Eye, sponsored by Sight Sciences.

Completed
Registry status
NA
Development phase
29
Enrollment target
3
Study locations

NCT03588624 is a NA study of Dry Eye that has completed, run by Sight Sciences. The registered enrollment target is 29 participants, below the 95-participant average among 41 other Dry Eye trials with a reported enrollment target (69% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03588624, a NA study of Dry Eye, has completed, sponsored by Sight Sciences.

COMPLETED
Registry status
NA
Development phase
29 participants
Enrollment target
3
Study locations

Study Summary

This study was conducted to evaluate the short-term (1 month) safety and effectiveness of a single TearCare procedure to treat adult patients with dry eye disease.

Conditions Studied

Dry Eye

Interventions

  • DEVICE TearCare

Study Locations (3)

California

  • Eye Research Institute - Newport Beach

Illinois

  • Arlington Eye Physicians - Arlington Heights

Kentucky

  • Kentucky Eye Institute - Lexington

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2018-07-12
Est. Completion 2018-11-08
Phase NA

Sponsor

Sight Sciences

14 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03588624

The ClinicalTrials.gov registry entry for NCT03588624 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 95-participant average among 41 other Dry Eye trials with a reported enrollment target (69% lower). The listed sponsor is Sight Sciences, which has 14 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dry Eye appearing as the primary indexed condition, and to 1 intervention - of which TearCare is the first listed.

NCT03588624 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, Illinois, Kentucky.

Frequently Asked Questions

What is clinical trial NCT03588624 about?

NCT03588624 is a clinical study titled "Study of the TearCare System in Dry Eye Disease". This study was conducted to evaluate the short-term (1 month) safety and effectiveness of a single TearCare procedure to treat adult patients with dry eye disease.

What is the current status of trial NCT03588624?

This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2018-07-12. Estimated completion is 2018-11-08.

What conditions does trial NCT03588624 study?

This clinical trial studies the following conditions: Dry Eye.

What interventions are being tested in trial NCT03588624?

The interventions under investigation include: TearCare (DEVICE).

Who is sponsoring clinical trial NCT03588624?

This trial is sponsored by Sight Sciences, which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03588624 being conducted?

This trial has 3 study locations across California, Illinois, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Dry Eye

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Dry Eye

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.